These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 23765252

  • 1. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.
    McConechy MK, Ding J, Senz J, Yang W, Melnyk N, Tone AA, Prentice LM, Wiegand KC, McAlpine JN, Shah SP, Lee CH, Goodfellow PJ, Gilks CB, Huntsman DG.
    Mod Pathol; 2014 Jan; 27(1):128-34. PubMed ID: 23765252
    [Abstract] [Full Text] [Related]

  • 2. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Huang HN, Lin MC, Tseng LH, Chiang YC, Lin LI, Lin YF, Huang HY, Kuo KT.
    Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
    [Abstract] [Full Text] [Related]

  • 3. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
    Ishikawa M, Nakayama K, Nakamura K, Ono R, Yamashita H, Ishibashi T, Minamoto T, Iida K, Razia S, Ishikawa N, Kyo S.
    Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219
    [Abstract] [Full Text] [Related]

  • 4. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, Noguchi M.
    Cancer Res; 2000 Dec 15; 60(24):7052-6. PubMed ID: 11156411
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.
    Ruz-Caracuel I, López-Janeiro Á, Heredia-Soto V, Ramón-Patino JL, Yébenes L, Berjón A, Hernández A, Gallego A, Ruiz P, Redondo A, Peláez-García A, Mendiola M, Hardisson D.
    Virchows Arch; 2021 Dec 15; 479(6):1167-1176. PubMed ID: 34420090
    [Abstract] [Full Text] [Related]

  • 8. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G, Gamallo C, Pérez-Gallego L, de Mora JC, Suárez A, Palacios J.
    Diagn Mol Pathol; 2001 Jun 15; 10(2):116-22. PubMed ID: 11385321
    [Abstract] [Full Text] [Related]

  • 9. [Molecular carcinogenesis of ovarian carcinoma].
    Diebold J.
    Verh Dtsch Ges Pathol; 2005 Jun 15; 89():77-83. PubMed ID: 18035676
    [Abstract] [Full Text] [Related]

  • 10. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
    Catasús L, Bussaglia E, Rodrguez I, Gallardo A, Pons C, Irving JA, Prat J.
    Hum Pathol; 2004 Nov 15; 35(11):1360-8. PubMed ID: 15668893
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
    Rambau PF, McIntyre JB, Taylor J, Lee S, Ogilvie T, Sienko A, Morris D, Duggan MA, McCluggage WG, Köbel M.
    Am J Surg Pathol; 2017 May 15; 41(5):685-695. PubMed ID: 28125452
    [Abstract] [Full Text] [Related]

  • 13. Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.
    Catasus L, Gallardo A, Cuatrecasas M, Prat J.
    Mod Pathol; 2009 Apr 15; 22(4):522-9. PubMed ID: 19234438
    [Abstract] [Full Text] [Related]

  • 14. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
    Hoang LN, McConechy MK, Köbel M, Han G, Rouzbahman M, Davidson B, Irving J, Ali RH, Leung S, McAlpine JN, Oliva E, Nucci MR, Soslow RA, Huntsman DG, Gilks CB, Lee CH.
    Am J Surg Pathol; 2013 Sep 15; 37(9):1421-32. PubMed ID: 24076778
    [Abstract] [Full Text] [Related]

  • 15. Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers.
    Moroney MR, Davies KD, Wilberger AC, Sheeder J, Post MD, Berning AA, Fisher C, Lefkowits C, Guntupalli SR, Behbakht K, Corr BR.
    Gynecol Oncol; 2019 Jun 15; 153(3):517-520. PubMed ID: 30910249
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CTNNB1 p.L31P mutation in an ovarian endometrioid carcinoma with synchronous uterine endometrioid carcinoma.
    Pecorella I, Coppa A, Nicolussi A, Manganaro L, Fiorentin F, Palaia I, Muzii L.
    Pathol Res Pract; 2020 Dec 15; 216(12):153260. PubMed ID: 33120166
    [Abstract] [Full Text] [Related]

  • 18. High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary.
    Oliva E, Sarrió D, Brachtel EF, Sánchez-Estévez C, Soslow RA, Moreno-Bueno G, Palacios J.
    J Pathol; 2006 Apr 15; 208(5):708-13. PubMed ID: 16429393
    [Abstract] [Full Text] [Related]

  • 19. PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas.
    Wappenschmidt B, Wardelmann E, Gehrig A, Schöndorf T, Maass N, Bonatz G, Gassel AM, Pietsch T, Mallmann P, Weber BH, Schmutzler RK.
    Hum Pathol; 2004 Oct 15; 35(10):1260-5. PubMed ID: 15492994
    [Abstract] [Full Text] [Related]

  • 20. Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer.
    Malentacchi F, Turrini I, Sorbi F, Projetto E, Castiglione F, Fambrini M, Petraglia F, Pillozzi S, Noci I.
    Oncol Rep; 2019 Mar 15; 41(3):1560-1574. PubMed ID: 30569174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.